Nivolumab plus ipilimumab induced endocrinopathy and acute interstitial nephritis in metastatic sarcomatoid renal-cell carcinoma: A case report and review of literature

The prognosis of sarcomatoid renal cell carcinoma has changed dramatically with the emergence of immune checkpoint inhibitors. Notably the use of nivolumab and ipilimumab combination therapy has demonstrated promising durable therapeutic response for patients with treatment-naïve sarcomatoid renal-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hino, Christopher, Nishino, Kevin, Pham, Bryan, Jeon, Won Jin, Nguyen, Michael, Cao, Huynh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425087/
https://www.ncbi.nlm.nih.gov/pubmed/36052087
http://dx.doi.org/10.3389/fimmu.2022.993622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425087/
https://www.ncbi.nlm.nih.gov/pubmed/36052087
http://dx.doi.org/10.3389/fimmu.2022.993622

Ejemplares similares